Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Irbesartan in Patients With Type 2 Diabetes and Microalbuminuria (IRMA 2)

NCT00317915 is registered in ClinicalTrials.gov with Steno Diabetes Center Copenhagen as lead sponsor.

NCT NCT00317915
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00317915 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Irbesartan in Patients With Type 2 Diabetes and Microalbuminuria (IRMA 2)
Lead sponsor
Steno Diabetes Center Copenhagen
Phase
Phase 3
Overall status
Completed
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, microalbuminuria, type 2 diabetes